Recently the manufacturer of DHASCO(DHA single cell organism) has reported the results of a study regarding benefits in brain development.At three times the current dosage,some benefit has been reported for females and none for males.Combining these results yielded no benefit from DHASCO supplementation improving cognive development.What this study revealed was the fact that DHASCO supplementation effects are different among gender.Parents of male infants pay an increased price for a benefit that does not exist.Keep in mind that females have shown some benefit but at three times the current dosage in infant formula today.After twelve years of DHASCO supplementation worldwide,the evidence supporting benefits are inconsistant.The FDA has approved DHASCO and ARASCO(ARA single cell organism)supplementation as GRAS(generally regarded as safe).The FDA is not responsible for the safety of infant formula ingredients.This is the responsibility of the manufacturer.I have obtained 176 pages of adverse reports to the FDA through the Freedom Of Information Act.These reports are from parents whose infants have experienced serious digestive issues and in some cases even death.The scientific and medical community are still investigating the exact way in which these polyunsaturated fatty acid supplements exert their effects in the human body.
